NasdaqCM - Nasdaq Real Time Price USD
Belite Bio, Inc (BLTE)
64.22
-1.06
(-1.62%)
At close: June 5 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
--
-29,234
-29,837
-11,458
-7,474
Investing Cash Flow
--
-110,572
-63
-394
-56
Financing Cash Flow
--
83,595
75,959
36,963
-583
End Cash Position
--
31,677
88,157
42,089
17,344
Income Tax Paid Supplemental Data
--
6
9
0
0
Interest Paid Supplemental Data
--
0
0
16
0
Capital Expenditure
--
-151
-63
-394
-74
Issuance of Capital Stock
--
42,236
55,188
37,990
0
Issuance of Debt
--
--
--
0
0
Repayment of Debt
--
--
--
0
0
Free Cash Flow
--
-29,385
-29,900
-11,852
-7,548
12/31/2021 - 4/29/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6696.TWO Lin BioScience, Inc.
140.00
+1.08%
7832.TWO Intelligene
12.30
-3.15%
NUVL Nuvalent, Inc.
78.09
+1.65%
ACLX Arcellx, Inc.
66.25
+1.18%
IMVT Immunovant, Inc.
16.02
+4.43%
PHVS Pharvaris N.V.
16.05
-3.43%
PCVX Vaxcyte, Inc.
34.80
+2.84%
CRNX Crinetics Pharmaceuticals, Inc.
32.32
+0.59%
APGE Apogee Therapeutics, Inc.
37.65
+3.15%
AKRO Akero Therapeutics, Inc.
53.94
+1.79%